ArticleProceedings of the National Academy of Sciences of the United States of America2013

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer.

Sherene Loi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.